Rethinking antiphospholipid syndrome to guide future management and research

JS Knight, D Erkan - Nature Reviews Rheumatology, 2024 - nature.com
Antiphospholipid syndrome (APS) consists of thrombotic, non-thrombotic and obstetric
clinical manifestations developing in individuals with persistent antiphospholipid antibodies …

[HTML][HTML] The ABCs of antiphospholipid syndrome

ABK Dinçer, D Erkan - Archives of Rheumatology, 2023 - ncbi.nlm.nih.gov
Antiphospholipid syndrome (APS) is a thromboinflammatory syndrome characterized by
thrombotic, microvascular, obstetric, or non-thrombotic events in the setting of persistent …

Plasma cell-free DNA as a monitoring tool for high-risk pregnancies associated with antiphospholipid syndrome

J Cepeda, ME Racca, MA Cardozo, L Gaydou… - Thrombosis …, 2024 - Elsevier
Introduction Despite thromboprophylaxis, women with antiphospholipid syndrome (APS)
face high-risk pregnancies due to proinflammatory and prothrombotic states. This highlights …

[HTML][HTML] The prevalence and incidence of thrombotic primary antiphospholipid syndrome in adults aged 18–49 years: A population-based study in a mountain …

L Andreoli, C Nalli, E Raffetti, F Angeli, G Pascariello… - Clinical …, 2024 - Elsevier
Objective To estimate prevalence and incidence of thrombotic Primary Antiphospholipid
Syndrome (PAPS) in the general population aged 18–49 years. Methods The study was …

El síndrome antifosfolípido: un nuevo enfoque cuatro décadas después de su inicial definición

MMP de Alejo Rodríguez, LR Jorge… - Medicentro …, 2024 - medicentro.sld.cu
Introducción: El síndrome antifosfolípido es una enfermedad tromboinflamatoria
autoinmune, con manifestaciones macro y microvasculares trombóticas y no trombóticas …